Last updated on January 2020

GB001 in Adult Subjects With Moderate to Severe Asthma


Brief description of study

A randomized, double-blind, placebo-controlled, dose-ranging, multi-center study to evaluate the efficacy and safety of GB001 when added to standard-of care (SOC) asthma maintenance therapy in adults with moderate to severe asthma and an eosinophilic phenotype with respect to asthma worsening at the end of 24 weeks of treatment.

Clinical Study Identifier: NCT03683576

Find a site near you

Start Over

Bensch Clinical Research LLC

Stockton, CA United States
  Connect »

Pulmonary Associates

Colorado Springs, CO United States
  Connect »

Yale New Haven Hospital

New Haven, CT United States
  Connect »

Emerald Coast Research Associates

Panama City, FL United States
  Connect »

Clinical Research Institute, Inc.

Minneapolis, MN United States
  Connect »

Atlantic Research Center, LLC

Ocean City, NJ United States
  Connect »

American Health Research

Charlotte, NC United States
  Connect »

Clinical Research of Charlotte

Charlotte, NC United States
  Connect »

Wake Forest Baptist Health

Winston-Salem, NC United States
  Connect »

Crisor, LLC

Medford, OR United States
  Connect »

Carolina Research

Orangeburg, SC United States
  Connect »

Cosicana Medical Research, LLC

Corsicana, TX United States
  Connect »

Baylor College of Medicine

Houston, TX United States
  Connect »

C.I.C. Mauricie Inc.

Trois-Rivières, QC Canada
  Connect »

MediTrial s.r.o.

Jindrichuv Hradec, Czechia
  Connect »

PNEUMO-KV s.r.o.

Karlovy Vary, Czechia
  Connect »

Medicon a.s.

Praha 4, Czechia
  Connect »

Schmid

Koblenz, Germany
  Connect »

Hospital Universitario de Bellvitge

L'Hospitalet de Llobregat, Spain
  Connect »

Bradford Royal Infirmary

Bradford, United Kingdom
  Connect »

C.I.C. Mauricie Inc.

Trois-Rivières, QC Canada
  Connect »

The Emory Clinic

Atlanta, GA United States
  Connect »

FAAR Institute LLC

Gaithersburg, MD United States
  Connect »

Cleveland Clinic

Cleveland, OH United States
  Connect »

C.I.C. Mauricie Inc.

Trois-Rivières, QC Canada
  Connect »

C. I. C Mauricie Inc.

Trois-Rivières, Canada
  Connect »

C.I.C. Mauricie Inc.

Trois-Rivières, QC Canada
  Connect »

C. I. C Mauricie Inc.

Trois-Rivières, Canada
  Connect »

Central Florida Pulmonary Group, PA

Altamonte Springs, FL United States
  Connect »

Clinical Research of Rock Hill

Rock Hill, SC United States
  Connect »

C.I.C. Mauricie Inc.

Trois-Rivières, QC Canada
  Connect »

C. I. C Mauricie Inc.

Trois-Rivières, Canada
  Connect »

Ostrowieckie Centrum Medyczne

Ostrowiec ?wi?tokrzyski, Poland
  Connect »

SPZOZ Proszowice

Proszowice, Poland
  Connect »

C.I.C. Mauricie Inc.

Trois-Rivières, QC Canada
  Connect »

C. I. C Mauricie Inc.

Trois-Rivières, Canada
  Connect »

Ostrowieckie Centrum Medyczne

Ostrowiec ?wi?tokrzyski, Poland
  Connect »